Our study, for the first time, elucidates the non-enzymatic role of CERS6, wherein its binding to Fas blocks the activation of the extrinsic apoptotic pathway in ALL cells upon treatment of anticancer drugs. The gene discussed is FAS; the disease is acute lymphoblastic leukemia.